GSE167360
RNA-seq of C3H/HeJ AA mice skin biopsies treated with JAK-selective inhibitors
To define the molecular response to JAKi treatment, we performed RNA-seq analysis on a series of skin biopsies taken before and after systemic treatment with INCB039110 (JAK1i), CEP-33779 (JAK2i), PF-06651600 (JAK3i), ruxolitinib (JAK1/2i), tofacitinib (pan-JAKi) or vehicle control. Overall design: mRNA profiles to JAKi treatment of C3H/HeJ AA mice.